Tag | Content |
---|
EnhancerAtlas ID | HS074-01353 |
Organism | Homo sapiens |
Tissue/cell | GM19239 |
Coordinate | chr1:226039470-226040360 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nr2f6(var.2) | MA0728.1 | chr1:226039969-226039984 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_04909 | chr1:226038991-226052376 | Brain_Cingulate_Gyrus | SE_05837 | chr1:226029277-226050904 | Brain_Hippocampus_Middle | SE_06795 | chr1:226029431-226048398 | Brain_Hippocampus_Middle_150 | SE_07978 | chr1:226039034-226046265 | Brain_Inferior_Temporal_Lobe | SE_11743 | chr1:226033094-226042126 | CD20 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I225851 | chr1 | 226039021 | 226040763 |
|
Enhancer Sequence | TCCCCCTAAA ACTCAGCTAT CACTGCCAGC AGTCTCTTGG GTTTTTTGTT TCCTTCTAGA 60 GCCTTTCATT AATCTGCCAG TTGCAGATGT TTTATTTCAG TGGCCAGGAC CTTGGTCTTT 120 AAACAGTCCT GAGTTCAAAG GCTGGTTCTC CTGCTTACTA ACAACATACG AAGTTATTTT 180 GTGTGAAGGG GGAATAGAAA CAGGAACTGC CTTGTAGGAT GAGGTGAGAA ATGTGGTAAT 240 CCACGTGGAG GCAGGCATCT GCCAGAGTGA AAGCAGCACG AGAGCTTTGA TTGTGACTCT 300 GGCACTGTCT TACTTGCTGC TAAAGAAATC AACCATGAAC GACATAGTCA GTGGGCAGAG 360 AACCTCAGAC CAGAAATACT AAGAGAGGTC CTAGCTGAGG GCCAGTGGGA GGAATTCATT 420 TAAAAATGAA TGAGGCCGGG TGCTGTGGCT CATGCCTATA ATCCCAGCAC TTTGGGAGGC 480 TGAGGCGGGT GGATCACCTG AGGTCAGGAG TTCAAGACCA GGCTGGCCAA CATGGTGAAA 540 CCCCATCTCT ACTAAAAATA CAAAAAGTTA GGCAGGCATG GTGGCGGGCA CCTGTAATCC 600 CAGCTACTCA GGAGGCTGAG ATGGGAGGAT GGCTTGAGCC CAGGAGGTGG GGGTTGCAGT 660 AAGCCAAGAT CATGCCACTC CAGCCTGGGC ATCAGCATGA GACCCTGTCT CAAAACAAAA 720 AAAGAAAGAA ATGAGTGAAA TCTGGTGTCA CGTGAGTCTT TAGCAGCTTG TGGCTCTTGT 780 GGCTGTGGTT TTGGGAACTC CATTGTGCCC TGGTGATAGC TGTCCCCGAG AGGTTTGGTG 840 CAATCAGCCG TCCATGTACC CATGTACCCT GGGACAGGCT CCAGGGCCAC 890
|